Stocks · News reference

Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est

Aug 14, 2026, 2:40 PMBenzinga Newsdesk

Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MLSS

Source: benzinga
Observed: Aug 14, 2026, 2:40 PM
Checked: Aug 14, 2026, 2:40 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 26, 2026, 1:07 PMBenzinga Newsdesk
Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that three members of its Board of Directors have converted
Read original at benzinga
MLSS
BenzingaAug 14, 2026, 4:53 PMBenzinga Newsdesk
Milestone Scientific shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance below analyst estimates.
Read original at benzinga
MLSS
BenzingaAug 14, 2026, 2:40 PMBenzinga Newsdesk
Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est
Milestone Scientific (AMEX:MLSS) sees Q3 sales of $2.300 million-$2.500 million vs $2.510 million analyst estimate.
Read original at benzinga
MLSS

Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est

Connected markets

Related headlines

Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet

Milestone Scientific shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance below analyst estimates.

Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est